<DOC>
	<DOCNO>NCT00503022</DOCNO>
	<brief_summary>This study evaluate tolerability safety single intravenous infusion ACZ885 . It also explore efficacy compound central macular edema visual acuity patient wet age-related macular edema .</brief_summary>
	<brief_title>Safety Tolerability Intravenous Infusion ACZ885 Patients With Wet Age-Related Macular Degeneration</brief_title>
	<detailed_description />
	<mesh_term>Macular Degeneration</mesh_term>
	<mesh_term>Choroidal Neovascularization</mesh_term>
	<criteria>Inclusion criterion : Male female â‰¥ 50 year old , age related macular degeneration Patients subfoveal choroidal neovascularization secondary agerelated macular degeneration Exclusion criterion : Active intraocular inflammation ocular infection study eye Eye disease may result visual loss study Chronic therapy topical , local systemic corticosteroid . Pregnant nursing ( lactate ) woman .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2007</verification_date>
	<keyword>Wet age-related macular degeneration</keyword>
	<keyword>ACZ885</keyword>
</DOC>